Amish Raval MD
Heart Failure & Transplantation, Interventional Cardiology, Peripheral Endovascular Interventional Cardiology
Assistant Professor, Medicine, University of Wisconsin Medical School
Join to View Full Profile
600 Highland aveMadison, WI 53792
Phone+1 608-263-1530
Dr. Raval is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington Hospital CenterFellowship, Endovascular and Structural Heart Interventions, 2003 - 2005
National Heart Lung and Blood InstitutePost-Doctoral Fellowship, 2003 - 2005
MedStar Health Georgetown UniversityFellowship, Interventional Cardiology, 2002 - 2003- OtherClass of 1996
University of Western OntarioClass of 1996- University of Western OntarioUndergraduate studies, Mathematics and Statistical Sciences, 1990 - 1992
- University of Western OntarioBachelor's, Mathematics and Statistical Sciences, 1990 - 1992
Certifications & Licensure
WI State Medical License 2005 - 2025
DC State Medical License 2002 - 2006
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Interventional Cardiology
Publications & Presentations
PubMed
- Intermediate monocytes in blood correlate with subclinical vascular changes in lupus nephritis.Shivani Garg, Sara S McCoy, Izzy Hartel, Abigail Muhlstock, Amish N Raval
Lupus Science & Medicine. 2025-02-06 - Comment on: Renal Arteriosclerosis in kidney biopsies associated with higher 10-year atherosclerotic cardiovascular disease in lupus nephritis: Reply.Shivani Garg, Brad Rovin, Amish N Raval, Christie M Bartels
Rheumatology. 2025-02-04 - Renal Arteriosclerosis in kidney biopsies associated with higher 10-year atherosclerotic cardiovascular disease in lupus nephritis.Shivani Garg, Brad C Astor, S Sam Lim, Amish N Raval, Weixiong Zhong
Rheumatology. 2024-12-19
Press Mentions
Biocardia Phase 3 CardiAMP-HF Trial of Novel Cardiac Cell Therapy for Ischemic Heart Failure Shows Increased Survival, Decreased Cardiac Events, and Improved Quality of Life at Two YearsMarch 31st, 2025- BioCardia Announces Late Breaking Clinical Trial Presentation on CardiAMP Heart Failure Trial at the American College of Cardiology 2025 Scientific SessionsJanuary 27th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
